PROCEPT BioRobotics® Announces First Commercial Aquablation Therapy Procedures in Japan
August 22, 2023 08:00 ET
|
PROCEPT BioRobotics
REDWOOD CITY, Calif., Aug. 22, 2023 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (NASDAQ: PRCT) (“PROCEPT BioRobotics”), a global leader in surgical robotics, announced today that it has...
PROCEPT BioRobotics to Present at the 2023 Wells Fargo Healthcare Conference in Boston
August 17, 2023 16:05 ET
|
PROCEPT BioRobotics
REDWOOD CITY, Calif., Aug. 17, 2023 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing...
NorthShore University HealthSystem offers expanded access to treat most common prostate ailment
August 16, 2023 08:00 ET
|
PROCEPT BioRobotics; NorthShore University HealthSystem
EVANSTON, Ill., Aug. 16, 2023 (GLOBE NEWSWIRE) -- NorthShore University HealthSystem (NorthShore) and PROCEPT BioRobotics® announce a significant milestone in access to treatment of Benign Prostatic...
PROCEPT BioRobotics Corporation Announces Pricing of Upsized Offering of Common Stock
August 01, 2023 22:10 ET
|
PROCEPT BioRobotics
REDWOOD CITY, Calif., Aug. 01, 2023 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (NASDAQ: PRCT) (“PROCEPT BioRobotics”), a surgical robotics company focused on advancing patient care by...
PROCEPT BioRobotics Corporation Announces Proposed Offering of Common Stock
August 01, 2023 16:06 ET
|
PROCEPT BioRobotics
REDWOOD CITY, Calif., Aug. 01, 2023 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (NASDAQ: PRCT) (“PROCEPT BioRobotics”), a surgical robotics company focused on advancing patient care by...
PROCEPT BioRobotics® Reports Second Quarter 2023 Financial Results and Increases 2023 Revenue Guidance
July 27, 2023 07:00 ET
|
PROCEPT BioRobotics
REDWOOD CITY, Calif., July 27, 2023 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing...
PROCEPT BioRobotics to Report Second Quarter 2023 Financial Results on July 27, 2023
July 11, 2023 16:03 ET
|
PROCEPT BioRobotics
REDWOOD CITY, Calif., July 11, 2023 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (the “Company”) (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing...
Five-Year Data from the WATER II Study Demonstrate Aquablation Therapy Delivers Significant Durable Improvement of Benign Prostatic Hyperplasia Symptoms while Preserving Sexual Function in Men with Large Prostates
April 28, 2023 08:00 ET
|
PROCEPT BioRobotics
5-Year results from WATER II when combined with 5-year results from the original WATER study demonstrate that Aquablation therapy provides long-term symptom relief while preserving sexual function for...
PROCEPT BioRobotics Reports First Quarter 2023 Financial Results and Increases 2023 Revenue Guidance
April 27, 2023 07:00 ET
|
PROCEPT BioRobotics
REDWOOD CITY, Calif., April 27, 2023 (GLOBE NEWSWIRE) -- PROCEPT® BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing...
PROCEPT BioRobotics to Report First Quarter 2023 Financial Results on April 27, 2023 and Present at the Bank of America 2023 Health Care Conference in Las Vegas
April 05, 2023 16:03 ET
|
PROCEPT BioRobotics
REDWOOD CITY, Calif., April 05, 2023 (GLOBE NEWSWIRE) -- PROCEPT® BioRobotics Corporation (the “Company”) (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing...